Are analysts right about Merit Medical Systems, Inc. (MMSI)?

Health Care · price $89.54 · median target $99.00 (+11%)

In short — Over the past 12 months, 38% of analyst price targets on Merit Medical Systems, Inc. turned out profitable, for an average return of +6% (across 143 timestamped calls). The current consensus is "Buy" with a median price target of $99.00 (+11% vs the current $89.54, from 8 analysts).

📈 See the interactive version (live chart) →

🔗 Related pages on Merit Medical Systems, Inc. — Financials & fundamentals · If I had invested

Current price

$89.54

Median target (12 mo)

$99.00 +11%

Analyst accuracy (1 yr)

38%

Avg return / call (1 yr)

+6%

💰 Performance & « if I invested » 📊 Interactive analysis

Historical analyst accuracy

For Merit Medical Systems, Inc., we replayed every analyst price target of the past 12 months and measured the real outcome: 38% were profitable, average return +6% (143 calls). At 3 months: +3% average return (51% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.

Analyst / broker	Calls i	% profitable i	Avg return i
Needham	31	26%	-2%
Raymond James	26	50%	+19%
Barrington Research	24	29%	+3%
Piper Sandler	19	37%	+10%
Canaccord Genuity	19	47%	+10%

Frequently asked questions

Is Merit Medical Systems, Inc. a buy right now?

The analyst consensus on Merit Medical Systems, Inc. (MMSI) is "Buy" (28 bullish, 0 bearish calls over 12 months). This is not advice: historically, 38% of their targets on this stock turned out profitable over 1 year.

What is Merit Medical Systems, Inc.'s price target?

The median 12-month price target is $99.00 (+11% vs $89.54), ranging from $83.00 to $107 (8 analysts).

Are analysts accurate on Merit Medical Systems, Inc.?

Over 1 year, 38% of analyst targets on Merit Medical Systems, Inc. were profitable, for an average return of +6% (across 143 timestamped calls). This is JPI Invest's accuracy metric.

What is the Merit Medical Systems, Inc. stock forecast?

Analysts target a median of $99.00 within 12 months, i.e. +11% vs the current price. The most bullish targets $107, the most cautious $83.00.

What is the Merit Medical Systems, Inc. stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $99.00, +11%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (38%), and the stock's past trajectory.

Is Merit Medical Systems, Inc. overvalued?

Detailed valuation data for Merit Medical Systems, Inc. is available in the interactive analysis.

📊 See the full interactive analysis of Merit Medical Systems, Inc. →

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
💬 AI assistant: ask anything about any stock, with the numbers
📊 Portfolio tracking + 🔔 price alerts by email

Explore JPI Invest for free → How it works: the method →

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.